MIRABEGRON 25 mg/1
mirabegron · TABLET, FILM COATED, EXTENDED RELEASE · Lupin Pharmaceuticals, Inc.
No Recall History
Plain English
MIRABEGRON is a tablet, film coated, extended release containing mirabegron at 25 mg/1, taken oral. Manufactured by Lupin Pharmaceuticals, Inc..
Key Facts
- Brand Name
- MIRABEGRON
- Generic Name
- mirabegron
- NDC Code (Product)
68180-151- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Strength
- 25 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA209485
- Drug Class
- beta3-Adrenergic Agonist [EPC]
- Marketing Start
- 04/19/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is MIRABEGRON used for?
MIRABEGRON contains mirabegron. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.
Is MIRABEGRON a controlled substance?
MIRABEGRON is not classified as a controlled substance by the DEA.
What is the generic name for MIRABEGRON?
The generic name for MIRABEGRON is mirabegron. There are 7 other brand versions of mirabegron.
What is the NDC code for MIRABEGRON 25 mg/1?
The NDC (National Drug Code) for MIRABEGRON 25 mg/1 is 68180-151, listed by Lupin Pharmaceuticals, Inc..